Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Camila Bach"'
Autor:
Camila Bach, Claudia Rita Corso, Alan de Almeida Veiga, Mariana Martins Paraizo, Lauro Mera de Souza
Publikováno v:
Pharmaceuticals, Vol 15, Iss 12, p 1486 (2022)
In South Brazil, the incidence of pediatric adrenocortical carcinoma (ACC) is higher than in other regions and countries worldwide. The ACC treatment includes therapy with mitotane, the only adrenolytic drug approved by the FDA. The mitotane metaboli
Externí odkaz:
https://doaj.org/article/a330858b86f9412c86caf190bef12ca9
Autor:
de Oliveira, Kauê Marcel, Abboud, Kahlile Youseff, Radulski, Débora Rasec, Faria, Bruna Christ, Galindo, Claudia Martins, Pereira, Gabriela Saidel, Stipp, Maria Carolina, Corso, Claudia Rita, de Assis, Camila Bach, de Lima Martins, Juliana Nunes, do Amaral, Luane Aparecida, Comar, Jurandir Fernando, Cordeiro, Lucimara Mach Côrtes, Acco, Alexandra
Publikováno v:
In International Journal of Biological Macromolecules October 2024 278 Part 3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sandro J.R. Bonatto, Alexandra Acco, Lauro Mera de Souza, Camila Bach, Claudia Rita Corso, Bonald C. Figueiredo
Publikováno v:
British Journal of Clinical Pharmacology. 87:2698-2710
Mitotane is the only adrenolytic drug approved by the Food and Drug Administration for treating adrenocortical carcinoma (ACC). This drug has cytotoxic effects on tumour tissues; it induces cell death and antisecretory effects on adrenal cells by inh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78c3ab3c4b4ccad14d8ae05fdc18ed3c
https://doi.org/10.1111/bcp.14721
https://doi.org/10.1111/bcp.14721